Literature DB >> 24988994

Genetics of Paget's disease of bone.

Stuart H Ralston1, Omar M E Albagha.   

Abstract

Paget's disease of bone (PDB) is a common condition, which is characterised by focal areas of increased and disorganized bone remodeling. Genetic factors play an important role in the disease. In some cases, Paget's disease is inherited in an autosomal dominant manner and the most common cause for this is a mutation in the SQSTM1 gene. Other familial cases have been linked to the OPTN locus on Chromosome 10p13 and still other variants have been identified by genome wide association studies that lie within or close to genes that play roles in osteoclast differentiation and function. Mutations in TNFRSF11A, TNFRSF11B and VCP have been identified in rare syndromes with PDB-like features. These advances have improved understanding of bone biology and the causes of PDB. The identification of genetic markers for PDB also raises the prospect that genetic profiling could identify patients at high risk of developing complications, permitting enhanced surveillance and early therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24988994     DOI: 10.1007/s11914-014-0219-y

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  60 in total

1.  Paget's disease of bone in New Zealand: continued decline in disease severity.

Authors:  H R Cundy; G Gamble; D Wattie; M Rutland; T Cundy
Journal:  Calcif Tissue Int       Date:  2004-10-07       Impact factor: 4.333

Review 2.  Pathogenesis of Paget disease of bone.

Authors:  Stuart H Ralston; Rob Layfield
Journal:  Calcif Tissue Int       Date:  2012-04-29       Impact factor: 4.333

3.  Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone.

Authors:  Micaela Rios Visconti; Anne L Langston; Nerea Alonso; Kirsteen Goodman; Peter L Selby; William D Fraser; Stuart H Ralston
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

4.  Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget's disease of bone.

Authors:  J R Cavey; S H Ralston; P W Sheppard; B Ciani; T R A Gallagher; J E Long; M S Searle; R Layfield
Journal:  Calcif Tissue Int       Date:  2006-05-06       Impact factor: 4.333

5.  Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis.

Authors:  A E Hughes; S H Ralston; J Marken; C Bell; H MacPherson; R G Wallace; W van Hul; M P Whyte; K Nakatsuka; L Hovy; D M Anderson
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

6.  Incidence and natural history of Paget's disease of bone in England and Wales.

Authors:  T P van Staa; P Selby; H G M Leufkens; K Lyles; J M Sprafka; C Cooper
Journal:  J Bone Miner Res       Date:  2002-03       Impact factor: 6.741

7.  Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.

Authors:  Wei Jin; Mikyoung Chang; Emmanuel M Paul; Geetha Babu; Andrew J Lee; William Reiley; Ato Wright; Minying Zhang; Jun You; Shao-Cong Sun
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

8.  Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences.

Authors:  Lynne J Hocking; Gavin J A Lucas; Anna Daroszewska; Tim Cundy; Geoff C Nicholson; Judit Donath; John P Walsh; Catriona Finlayson; James R Cavey; Barbara Ciani; Paul W Sheppard; Mark S Searle; Robert Layfield; Stuart H Ralston
Journal:  J Bone Miner Res       Date:  2004-03-22       Impact factor: 6.741

9.  Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone.

Authors:  Stuart H Ralston; Muhammad A Afzal; Miep H Helfrich; William D Fraser; James A Gallagher; Andrew Mee; Bert Rima
Journal:  J Bone Miner Res       Date:  2007-04       Impact factor: 6.741

10.  Epidemiology of Paget's disease in Europe: the prevalence is decreasing.

Authors:  Gyula Poór; Judit Donáth; Béla Fornet; Cyrus Cooper
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

View more
  10 in total

1.  Fine mapping of bone structure and strength QTLs in heterogeneous stock rat.

Authors:  Imranul Alam; Daniel L Koller; Toni Cañete; Gloria Blázquez; Carme Mont-Cardona; Regina López-Aumatell; Esther Martínez-Membrives; Sira Díaz-Morán; Adolf Tobeña; Alberto Fernández-Teruel; Pernilla Stridh; Margarita Diez; Tomas Olsson; Martina Johannesson; Amelie Baud; Michael J Econs; Tatiana Foroud
Journal:  Bone       Date:  2015-08-19       Impact factor: 4.398

Review 2.  The genetics of bone mass and susceptibility to bone diseases.

Authors:  David Karasik; Fernando Rivadeneira; Mark L Johnson
Journal:  Nat Rev Rheumatol       Date:  2016-04-07       Impact factor: 20.543

3.  Epigenetic DNA Methylation Signatures Associated With the Severity of Paget's Disease of Bone.

Authors:  Ilhame Diboun; Sachin Wani; Stuart H Ralston; Omar M E Albagha
Journal:  Front Cell Dev Biol       Date:  2022-06-13

Review 4.  How rare bone diseases have informed our knowledge of complex diseases.

Authors:  Mark L Johnson
Journal:  Bonekey Rep       Date:  2016-09-21

5.  Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's disease.

Authors:  Henry C Tseng; Ching-Chang Ko; Jennifer Martinez; Sing-Wai Wong; Bo-Wen Huang; Xiangxiang Hu; Eui Ho Kim; Joseph P Kolb; Ricardo J Padilla; Peng Xue; Lufei Wang; Thomas H Oguin; Patricia A Miguez
Journal:  Cell Death Differ       Date:  2019-05-10       Impact factor: 15.828

6.  Molecular insights into an ancient form of Paget's disease of bone.

Authors:  Barry Shaw; Carla L Burrell; Darrell Green; Ana Navarro-Martinez; Daniel Scott; Anna Daroszewska; Rob van 't Hof; Lynn Smith; Frank Hargrave; Sharad Mistry; Andrew Bottrill; Benedikt M Kessler; Roman Fischer; Archana Singh; Tamas Dalmay; William D Fraser; Kirstin Henneberger; Turi King; Silvia Gonzalez; Robert Layfield
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

7.  The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-κB signalling function.

Authors:  Melanie A Sultana; Carmel Cluning; Wai-Sin Kwong; Nicole Polain; Nathan J Pavlos; Thomas Ratajczak; John P Walsh; Jiake Xu; Sarah L Rea
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

8.  Clinical Characteristics and Pathogenic Gene Identification in Chinese Patients With Paget's Disease of Bone.

Authors:  Xiaohui Tao; Li Liu; Xingguang Yang; Zhe Wei; Zhongzhong Chen; Ge Zhang; Zhenlin Zhang; Hua Yue
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

9.  The Paget's disease of bone risk gene PML is a negative regulator of osteoclast differentiation and bone resorption.

Authors:  Sachin Wani; Anna Daroszewska; Donald M Salter; Rob J van 't Hof; Stuart H Ralston; Omar M E Albagha
Journal:  Dis Model Mech       Date:  2022-04-26       Impact factor: 5.732

10.  Paget's disease of bone: when and why to refer to specialist care.

Authors:  Catherine Nairn; Stuart H Ralston
Journal:  Br J Gen Pract       Date:  2020-10-29       Impact factor: 5.386

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.